Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2024 08:00 ET | Source: Med Tech Gurus

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
June 24, 2024 12:41 ET | Source: PRISM MarketView

Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move

Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
June 03, 2024 14:13 ET | Source: PRISM MarketView

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
May 30, 2024 16:47 ET | Source: OncoCyte Corporation

Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine

Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
May 15, 2024 16:05 ET | Source: OncoCyte Corporation

Oncocyte Reports First Quarter 2024 Financial Results

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
May 13, 2024 08:00 ET | Source: OncoCyte Corporation

Oncocyte to Announce First Quarter 2024 Financial Results

Oncocyte to Announce First Quarter 2024 Financial Results
May 07, 2024 09:19 ET | Source: PRISM MarketView

PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace

PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
April 12, 2024 06:00 ET | Source: OncoCyte Corporation

Oncocyte Reports Full Year 2023 Financial Results

ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
April 11, 2024 21:46 ET | Source: OncoCyte Corporation

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
April 11, 2024 17:30 ET | Source: OncoCyte Corporation

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay